Cellebrite DI Ltd. (CLBT)
| Market Cap | 2.70B -39.7% |
| Revenue (ttm) | 537.28M +17.9% |
| Net Income | 64.71M -14.6% |
| EPS | 0.25 -20.2% |
| Shares Out | 250.79M |
| PE Ratio | 43.02 |
| Forward PE | 16.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,788,035 |
| Open | 11.18 |
| Previous Close | 11.32 |
| Day's Range | 10.72 - 11.41 |
| 52-Week Range | 9.58 - 19.39 |
| Beta | 1.01 |
| Analysts | Strong Buy |
| Price Target | 15.43 (+43.54%) |
| Earnings Date | Nov 12, 2026 |
About CLBT
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property thef... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for CLBT stock is "Strong Buy." The 12-month stock price target is $15.43, which is an increase of 43.54% from the latest price.
News
Cellebrite price target lowered to $15 from $16 at JPMorgan
JPMorgan lowered the firm’s price target on Cellebrite (CLBT) to $15 from $16 and keeps an Overweight rating on the shares. The firm sees an attractive setup for the company…
Cellebrite DI Earnings Call Transcript: Q3 2026
Q3 ARR grew 20% and revenue 18%, both above guidance; adjusted EBITDA rose 42%. Genesis reached $2 million ARR, while FY ARR guidance was reaffirmed and adjusted EBITDA outlook raised.
Cellebrite DI Slides: Q3 2026
Cellebrite DI has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 12, 2026.
Cellebrite DI Earnings release: Q3 2026
Cellebrite DI released its Q3 2026 earnings on November 12, 2026, summarizing the period's financial results.
Cellebrite reports Q3 adjusted EPS 17c, consensus 16c
Reports Q3 revenue $149M, consensus $145.89M. Shiv Ramji, Cellebrite’s (CLBT) CEO, stated, “Cellebrite executed better in the third quarter, with ARR, revenue and adjusted EBITDA all finishing above o...
Cellebrite Reports Third-Quarter 2026 Results
Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin ...
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 9, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public...
Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development
Former Okta and SAP strategy leader brings AI, platform and M&A expertise to accelerate Cellebrite's growth TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 5, 2026 /PRNewswire/ -- Cellebrite (Nasdaq:...
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
Investigators report dramatic gains in what they uncover using Agentic AI vs. manual review; the Autumn 2026 Release brings expanded device and operating system access TYSONS CORNER, Va.
Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses
New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ...
Kaplan Fox Reminds Investors of Cellebrite DI Ltd. (CLBT) of an Ongoing Securities Investigation
New York, New York--(Newsfile Corp. - September 30, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NAS...
Kaplan Fox Advises Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NAS...
Cellebrite Calls for 2027 JUSTYS Nominees, Premier Event Highlights Unsung Heroes Who Keep the World Safe
Law&Crime Network and NewsNation anchor Jesse Weber returns to host; ceremony to stream live to Law&Crime Network's 7.7 million YouTube subscribers during Cellebrite's annual C2C User Summit in April ...
Kaplan Fox Notifies Investors of Cellebrite DI Ltd. (CLBT) of a Securities Law Investigation
New York, New York--(Newsfile Corp. - September 22, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NAS...
Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NAS...
CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $CLBT--CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS Law.
Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals
Purpose-built platform connects customers worldwide with peers and Cellebrite experts into an always-on community TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (CLBT) to a Securities Law Investigation
New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NAS...
Kaplan Fox Announces an Investigation into Cellebrite DI Ltd. (CLBT) on Behalf of Investors
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NAS...
Cellebrite DI Transcript: Fireside chat
Management outlined a strategic shift toward a unified investigative intelligence platform, emphasizing AI, cloud, and hardware innovation. Early adoption of new products is promising, with growth products set to increase ARR mix and redomiciling expected to ease federal sales cycles.
Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research
Strategic move strengthens Cellebrite's flagship access, extraction and decoding technology as Cellebrite Labs joins Wade's Innovation Hub TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
Cellebrite announces plans to redomicile in the United States
Cellebrite (CLBT) announced that the company’s Board of Directors has authorized Cellebrite to pursue a corporate reorganization, establishing a new United States corporation as the ultimate parent co...
Cellebrite Initiates Plans to Redomicile in the United States
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights
New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASD...
Cellebrite Announces Upcoming Investor Events in September
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.